Gavi, the Vaccine Alliance today announced that certain countries it supports can now apply to introduce four additional vaccines: preventive Ebola, human rabies vaccine for post-exposure prophylaxis, multivalent meningococcal conjugate, and hepatitis B birth dose.
These four vaccine programs were previously approved by the Gavi Board but were put on hold due to the recent pandemic.
The latest expansion of Gavi's vaccine portfolio aligns with its commitment to ensuring that lower-income countries access impactful vaccines as soon as possible.
Gavi Launches Preventive Vaccine Program for Ebola and Other Diseases
U.S. Health Industry Forecasted to Reach $7.7 Trillion
While the U.S. economy continues to expand, the health industry is forecasted to exceed the growth in gross domestic product (GDP).
During the entire projection period (2023–32), growth in national health expenditures is projected to average 5.6% and outpace the nominal GDP growth rate of 4.3%.
The estimated amount spent on hospital care, clinical services, drugs (including vaccines), and other health services in 2023 reached an all-time high of $4.1 trillion.
Residual Risk Seen for Death, Postacute Sequelae in Third Year After COVID-19 Hospitalization
Risk for death remains significantly elevated in third year, as is risk for incident postacute sequelae of COVID-19
Health Care Spending Growth Projected to Outpace GDP to 2032
National health expenditures projected to have increased 7.5 percent in 2023, when COVID-19 public health emergency ended